» Articles » PMID: 26276631

Hybrid Periportal Hepatocytes Regenerate the Injured Liver Without Giving Rise to Cancer

Abstract

Compensatory proliferation triggered by hepatocyte loss is required for liver regeneration and maintenance but also promotes development of hepatocellular carcinoma (HCC). Despite extensive investigation, the cells responsible for hepatocyte restoration or HCC development remain poorly characterized. We used genetic lineage tracing to identify cells responsible for hepatocyte replenishment following chronic liver injury and queried their roles in three distinct HCC models. We found that a pre-existing population of periportal hepatocytes, located in the portal triads of healthy livers and expressing low amounts of Sox9 and other bile-duct-enriched genes, undergo extensive proliferation and replenish liver mass after chronic hepatocyte-depleting injuries. Despite their high regenerative potential, these so-called hybrid hepatocytes do not give rise to HCC in chronically injured livers and thus represent a unique way to restore tissue function and avoid tumorigenesis. This specialized set of pre-existing differentiated cells may be highly suitable for cell-based therapy of chronic hepatocyte-depleting disorders.

Citing Articles

SOX9 Overexpression Ameliorates Metabolic Dysfunction-associated Steatohepatitis Through Activation of the AMPK Pathway.

Deng J, Ding K, Liu S, Chen F, Huang R, Xu B J Clin Transl Hepatol. 2025; 13(3):189-199.

PMID: 40078197 PMC: 11894392. DOI: 10.14218/JCTH.2024.00197.


Application of mesenchymal stem cells in liver fibrosis and regeneration.

Liu Z, Ren J, Qiu C, Wang Y, Zhang T Liver Res. 2025; 8(4):246-258.

PMID: 39958916 PMC: 11771278. DOI: 10.1016/j.livres.2024.11.004.


Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics.

Ma X, Huang T, Chen X, Li Q, Liao M, Fu L Signal Transduct Target Ther. 2025; 10(1):63.

PMID: 39920130 PMC: 11806117. DOI: 10.1038/s41392-024-02104-8.


Decoding liver fibrogenesis with single-cell technologies.

Zhou T, Kiran M, Lui K, Ding Q Life Med. 2025; 1(3):333-344.

PMID: 39872749 PMC: 11749458. DOI: 10.1093/lifemedi/lnac040.


FBP1 controls liver cancer evolution from senescent MASH hepatocytes.

Gu L, Zhu Y, Nandi S, Lee M, Watari K, Bareng B Nature. 2025; 637(8045):461-469.

PMID: 39743585 DOI: 10.1038/s41586-024-08317-9.


References
1.
Kisseleva T, Gigante E, Brenner D . Recent advances in liver stem cell therapy. Curr Opin Gastroenterol. 2010; 26(4):395-402. DOI: 10.1097/MOG.0b013e32833a6bec. View

2.
Schmelzer E, Zhang L, Bruce A, Wauthier E, Ludlow J, Yao H . Human hepatic stem cells from fetal and postnatal donors. J Exp Med. 2007; 204(8):1973-87. PMC: 2118675. DOI: 10.1084/jem.20061603. View

3.
Jungermann K, Katz N . Functional specialization of different hepatocyte populations. Physiol Rev. 1989; 69(3):708-64. DOI: 10.1152/physrev.1989.69.3.708. View

4.
Blanpain C, Fuchs E . Stem cell plasticity. Plasticity of epithelial stem cells in tissue regeneration. Science. 2014; 344(6189):1242281. PMC: 4523269. DOI: 10.1126/science.1242281. View

5.
Espanol-Suner R, Carpentier R, Van Hul N, Legry V, Achouri Y, Cordi S . Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology. 2012; 143(6):1564-1575.e7. DOI: 10.1053/j.gastro.2012.08.024. View